Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting

Hematologic Oncology Update

00:00

Inhibition of ACVR1 in Malle Fibrosis Transplant

The overall general mortality rate is somewhere in 2020 in a five percent range. I would suggest typically my patients to go to the very experienced large center for malle fibrosis transplant specifically. You asked me in the past about pachrytonic. I proved for patients with lower platelets below 54 control the spleen. Of course, it will improve the quality of life.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app